group_id,Component_23,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00938,1.4393787232539477,FUN_004288-T1,Peve_00029197,Pocillopora_meandrina_HIv1___RNAseq.g11767.t1,three_way,35.059,,,,,,,,,,,,,,,,,
OG_03108,1.389877155434079,FUN_012405-T1,Peve_00002856,Pocillopora_meandrina_HIv1___RNAseq.g9951.t1,three_way,66.98066666666666,,,,,,,,,,,,,,,,,
OG_02532,1.3321976231684802,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_08097,1.3315086210299176,FUN_035839-T1,Peve_00032500,Pocillopora_meandrina_HIv1___RNAseq.g11958.t2,three_way,68.27866666666667,,,,,,,,,,,,,,,,,
OG_01091,1.320633005364538,FUN_004584-T1,Peve_00012393,Pocillopora_meandrina_HIv1___RNAseq.g6602.t1,three_way,49.74033333333333,,,,,,,,,,,,,,,,,
OG_02968,1.3065478058405398,FUN_012130-T1,Peve_00035469,Pocillopora_meandrina_HIv1___RNAseq.g23786.t1,three_way,43.8205,FUN_012130-T1,Q5R7K9,,,,,32.1,156.0,7.5e-10,66.6,sp|Q5R7K9|EDIL3_PONAB EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Pongo abelii OX=9601 GN=EDIL3 PE=2 SV=1,,,,,,
OG_06305,1.303913559118695,FUN_028511-T1,Peve_00008102,Pocillopora_meandrina_HIv1___RNAseq.g14117.t1,three_way,72.03616666666667,FUN_028511-T1,Q6GLC9,FMR1_XENTR,,Fragile X messenger ribonucleoprotein 1 homolog (XtFmrp),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),45.6,377.0,2e-87,324.7,sp|Q6GLC9|FMR1_XENTR Fragile X messenger ribonucleoprotein 1 homolog OS=Xenopus tropicalis OX=8364 GN=fmr1 PE=2 SV=1,GO:0000381; GO:0000775; GO:0002092; GO:0002151; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006281; GO:0006397; GO:0006406; GO:0007215; GO:0007399; GO:0008017; GO:0008266; GO:0008380; GO:0010369; GO:0010494; GO:0010629; GO:0014069; GO:0017148; GO:0030371; GO:0030424; GO:0030425; GO:0030426; GO:0032433; GO:0033592; GO:0034046; GO:0034063; GO:0035195; GO:0035197; GO:0035198; GO:0035613; GO:0036464; GO:0042734; GO:0042803; GO:0042995; GO:0043005; GO:0043197; GO:0043204; GO:0043232; GO:0043488; GO:0043679; GO:0045202; GO:0045211; GO:0045727; GO:0045947; GO:0046928; GO:0046982; GO:0048027; GO:0048471; GO:0051028; GO:0051489; GO:0051491; GO:0060538; GO:0060965; GO:0060998; GO:0060999; GO:0070840; GO:0071598; GO:0097386; GO:0098793; GO:0098794; GO:0098908; GO:0140006; GO:0140693; GO:0140694; GO:1900453; GO:1901386; GO:1901800; GO:1902737; GO:1990247; GO:1990812; GO:1990825; GO:1990904; GO:2000301; GO:2000637; GO:2000766,"DNA repair [GO:0006281]; glutamate receptor signaling pathway [GO:0007215]; membraneless organelle assembly [GO:0140694]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of receptor internalization [GO:0002092]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]; skeletal muscle organ development [GO:0060538]; stress granule assembly [GO:0034063]","axon [GO:0030424]; axon terminus [GO:0043679]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; intracellular membraneless organelle [GO:0043232]; neuron projection [GO:0043005]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]",chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; histone H3 reader activity [GO:0140006]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; molecular condensate scaffold activity [GO:0140693]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation repressor activity [GO:0030371],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006913; GO:0008092; GO:0016071; GO:0016853; GO:0031047; GO:0043226; GO:0045182; GO:0048856; GO:0060090; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; nucleocytoplasmic transport; cytoskeletal protein binding; mRNA metabolic process; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; translation regulator activity; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA"
OG_01759,1.285592051558827,FUN_007111-T1,Peve_00017835,Pocillopora_meandrina_HIv1___RNAseq.g19017.t1,three_way,39.03566666666666,,,,,,,,,,,,,,,,,
OG_03659,1.2833375526112436,FUN_014896-T1,Peve_00003546,Pocillopora_meandrina_HIv1___RNAseq.g21104.t1,three_way,65.60683333333333,FUN_014896-T1,Q69ZX6,MOR2A_MOUSE,,ATPase MORC2A (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2A) (Zinc finger CW-type coiled-coil domain protein 1),Mus musculus (Mouse),41.3,920.0,5.7999999999999996e-151,536.6,sp|Q69ZX6|MOR2A_MOUSE ATPase MORC2A OS=Mus musculus OX=10090 GN=Morc2a PE=1 SV=2,GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042393; GO:0042803; GO:0140719; GO:0141005,chromatin remodeling [GO:0006338]; constitutive heterochromatin formation [GO:0140719]; DNA damage response [GO:0006974]; transposable element silencing by heterochromatin formation [GO:0141005],cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0016787; GO:0042393; GO:0043226,catalytic activity; nucleus; cytosol; chromatin organization; hydrolase activity; histone binding; organelle
OG_07455,1.2587222239800284,FUN_033951-T1,Peve_00032117,Pocillopora_meandrina_HIv1___RNAseq.g28360.t1,three_way,65.717,,,,,,,,,,,,,,,,,
OG_01092,1.187811430668725,FUN_004588-T1,Peve_00012396,Pocillopora_meandrina_HIv1___RNAseq.g6598.t1,three_way,60.343833333333336,,,,,,,,,,,,,,,,,
OG_08842,1.185911282443593,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_06132,1.165495415892539,FUN_027938-T2,Peve_00032459,Pocillopora_meandrina_HIv1___RNAseq.g14030.t1,three_way,71.97066666666667,,,,,,,,,,,,,,,,,
OG_06187,1.1599346209102004,FUN_028099-T2,Peve_00004894,Pocillopora_meandrina_HIv1___RNAseq.g15574.t1,three_way,79.82566666666666,FUN_028099-T2,Q7ZUW2,,,,,57.3,913.0,4.6e-213,743.0,sp|Q7ZUW2|HYOU1_DANRE Hypoxia up-regulated protein 1 OS=Danio rerio OX=7955 GN=hyou1 PE=2 SV=1,,,,,,
OG_00531,1.1563428601902048,FUN_001545-T1,Peve_00033291,Pocillopora_meandrina_HIv1___RNAseq.g15386.t1,three_way,49.809666666666665,,,,,,,,,,,,,,,,,
OG_08098,1.1551215694998345,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_07218,1.149616308680215,FUN_032790-T1,Peve_00010373,Pocillopora_meandrina_HIv1___RNAseq.g29721.t1,three_way,55.391333333333336,FUN_032790-T1,Q68LP1,MIB2_RAT,,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Rattus norvegicus (Rat),38.8,456.0,1.5999999999999999e-83,312.8,sp|Q68LP1|MIB2_RAT E3 ubiquitin-protein ligase MIB2 OS=Rattus norvegicus OX=10116 GN=Mib2 PE=1 SV=2,GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005886; GO:0007219; GO:0008270; GO:0016567; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation protein catabolic process at postsynapse [GO:0140252],cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005886; GO:0008092; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; plasma membrane; cytoskeletal protein binding; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_09440,1.1484396819744014,FUN_041426-T1,Peve_00008987,Pocillopora_meandrina_HIv1___RNAseq.g15735.t2,three_way,80.48633333333333,FUN_041426-T1,P97360,ETV6_MOUSE,,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),Mus musculus (Mouse),44.6,65.0,1.7e-11,70.9,sp|P97360|ETV6_MOUSE Transcription factor ETV6 OS=Mus musculus OX=10090 GN=Etv6 PE=1 SV=1,GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005730; GO:0005829; GO:0006355; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0045944; GO:0071425; GO:0097152,cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; vitellogenesis [GO:0007296],cytosol [GO:0005829]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005730; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleolus; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; transcription regulator activity
OG_01354,1.1269703127568207,FUN_005267-T1,Peve_00003352,Pocillopora_meandrina_HIv1___RNAseq.g8154.t1,three_way,58.39033333333333,FUN_005267-T1,B5X4E0,,,,,38.4,289.0,2.6000000000000003e-44,180.6,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_03696,1.1165755681739105,FUN_014965-T1,Peve_00006259,Pocillopora_meandrina_HIv1___RNAseq.g21129.t1,three_way,85.602,FUN_014965-T1,Q8TBY9,,,,,45.2,938.0,2.5999999999999998e-244,846.7,sp|Q8TBY9|CF251_HUMAN Cilia- and flagella-associated protein 251 OS=Homo sapiens OX=9606 GN=CFAP251 PE=1 SV=2,,,,,,
OG_04784,1.1046438211603669,FUN_022696-T1,Peve_00045102,Pocillopora_meandrina_HIv1___TS.g22242.t1,three_way,67.26566666666666,,,,,,,,,,,,,,,,,
OG_06896,1.072138616155223,FUN_031938-T1,Peve_00024799,Pocillopora_meandrina_HIv1___RNAseq.g18210.t1,three_way,53.64366666666667,,,,,,,,,,,,,,,,,
OG_09596,1.0710611977237388,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_07286,1.067478666160387,FUN_033666-T1,Peve_00006805,Pocillopora_meandrina_HIv1___RNAseq.g28824.t1,three_way,56.083,,,,,,,,,,,,,,,,,
OG_02226,1.067209874372929,FUN_008631-T1,Peve_00012388,Pocillopora_meandrina_HIv1___RNAseq.g14912.t1,three_way,62.56166666666666,,,,,,,,,,,,,,,,,
OG_02936,1.056584183084267,FUN_012041-T2,Peve_00016078,Pocillopora_meandrina_HIv1___RNAseq.g24062.t1,three_way,80.87033333333333,FUN_012041-T2,Q5TCS8,KAD9_HUMAN,,Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2),Homo sapiens (Human),43.5,1918.0,0.0,1171.4,sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2,GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0016887; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145,CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],(d)CMP kinase activity [GO:0004127]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CMP kinase activity [GO:0036430]; dCMP kinase activity [GO:0036431]; deoxyadenylate kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005929; GO:0016740; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; cilium; transferase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03147,1.0496296695297294,FUN_012533-T1,Peve_00034230,Pocillopora_meandrina_HIv1___RNAseq.g23954.t1,three_way,57.28066666666667,,,,,,,,,,,,,,,,,
OG_08487,1.046352085246558,FUN_037323-T1,Peve_00006230,Pocillopora_meandrina_HIv1___RNAseq.g10700.t1,three_way,56.69433333333333,FUN_037323-T1,B3LYS5,,,,,43.9,123.0,2e-18,94.7,sp|B3LYS5|FOXO_DROAN Forkhead box protein O OS=Drosophila ananassae OX=7217 GN=foxo PE=3 SV=2,,,,,,
OG_06891,1.044149311152119,FUN_031930-T1,Peve_00004237,Pocillopora_meandrina_HIv1___RNAseq.g18237.t1,three_way,54.86833333333333,,,,,,,,,,,,,,,,,
OG_01957,1.0384967282066162,FUN_008025-T1,Peve_00011341,Pocillopora_meandrina_HIv1___RNAseq.g30350.t1,three_way,62.04266666666667,,,,,,,,,,,,,,,,,
OG_03318,1.033851173799191,FUN_013396-T1,Peve_00028088,Pocillopora_meandrina_HIv1___TS.g15820.t1,three_way,43.746,,,,,,,,,,,,,,,,,
OG_05069,1.0326332670114853,FUN_023272-T1,Peve_00031864,Pocillopora_meandrina_HIv1___RNAseq.g17803.t1,three_way,64.60916666666667,FUN_023272-T1,Q9Z1Z1,E2AK3_RAT,,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (Protein tyrosine kinase EIF2AK3) (EC 2.7.10.2),Rattus norvegicus (Rat),35.6,1035.0,9.7e-144,512.7,sp|Q9Z1Z1|E2AK3_RAT Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Rattus norvegicus OX=10116 GN=Eif2ak3 PE=1 SV=1,GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006412; GO:0006446; GO:0006983; GO:0007029; GO:0007595; GO:0009967; GO:0010575; GO:0010628; GO:0010629; GO:0017148; GO:0019217; GO:0019722; GO:0019899; GO:0019903; GO:0030282; GO:0030968; GO:0031016; GO:0031018; GO:0031642; GO:0032055; GO:0032933; GO:0034198; GO:0034976; GO:0036499; GO:0036503; GO:0042149; GO:0042802; GO:0043066; GO:0044233; GO:0044322; GO:0045444; GO:0045943; GO:0048009; GO:0048471; GO:0051787; GO:0051879; GO:0060734; GO:0070059; GO:0070417; GO:0106310; GO:1900182; GO:1902010; GO:1902235; GO:1902237; GO:1903788; GO:1990737,angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation [GO:0006446]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005783; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06279,1.032271698395208,FUN_028447-T1,Peve_00026233,Pocillopora_meandrina_HIv1___RNAseq.g16195.t1,three_way,59.692,FUN_028447-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),40.3,573.0,9.700000000000001e-117,423.7,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_02531,1.027450825236183,FUN_010606-T1,Peve_00032719,Pocillopora_meandrina_HIv1___RNAseq.g21491.t1,three_way,76.36316666666666,FUN_010606-T1,Q5SSZ7,ZNRF3_MOUSE,,E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3),Mus musculus (Mouse),50.3,302.0,2.7e-80,300.8,sp|Q5SSZ7|ZNRF3_MOUSE E3 ubiquitin-protein ligase ZNRF3 OS=Mus musculus OX=10090 GN=Znrf3 PE=1 SV=1,GO:0004842; GO:0005109; GO:0005886; GO:0006511; GO:0008270; GO:0016055; GO:0016567; GO:0030178; GO:0038018; GO:0060173; GO:0060828; GO:0072089; GO:0090090; GO:2000051; GO:2000095,"limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]",plasma membrane [GO:0005886],frizzled binding [GO:0005109]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_03495,1.0267366938422988,FUN_014604-T1,Peve_00028205,Pocillopora_meandrina_HIv1___RNAseq.g22749.t1,three_way,70.68266666666666,FUN_014604-T1,A2BGR3,,,,,54.5,635.0,3.2000000000000004e-185,650.2,sp|A2BGR3|ERC6L_DANRE DNA excision repair protein ERCC-6-like OS=Danio rerio OX=7955 GN=ercc6l PE=1 SV=1,,,,,,
OG_06576,1.0235366101299912,FUN_029521-T2,Peve_00028580,Pocillopora_meandrina_HIv1___RNAseq.g17111.t1,three_way,61.62799999999999,FUN_029521-T2,P0DN10,,,,,63.5,52.0,2.7e-14,83.6,sp|P0DN10|VKT6_ANEVI U-actitoxin-Avd3i OS=Anemonia viridis OX=51769 PE=3 SV=1,,,,,,
OG_07872,1.0231843141444286,FUN_035231-T1,Peve_00044486,Pocillopora_meandrina_HIv1___RNAseq.g27905.t1,three_way,73.57433333333333,,,,,,,,,,,,,,,,,
OG_05809,1.022501038037929,FUN_025809-T2,Peve_00017944,Pocillopora_meandrina_HIv1___TS.g19642.t2,three_way,56.2395,FUN_025809-T2,Q08EN7,,,,,29.7,286.0,1.6e-26,122.5,sp|Q08EN7|ZCPW2_MOUSE Zinc finger CW-type PWWP domain protein 2 homolog OS=Mus musculus OX=10090 GN=Zcwpw2 PE=2 SV=2,,,,,,
OG_00225,1.017189434599073,FUN_000960-T1,Peve_00021379,Pocillopora_meandrina_HIv1___RNAseq.13437_t,three_way,86.795,FUN_000960-T1,P28271,ACOHC_MOUSE,,Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1),Mus musculus (Mouse),71.1,869.0,0.0,1303.1,sp|P28271|ACOHC_MOUSE Cytoplasmic aconitate hydratase OS=Mus musculus OX=10090 GN=Aco1 PE=1 SV=3,GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006740; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0046872; GO:0050892; GO:0051538; GO:0051539,citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; NADPH regeneration [GO:0006740]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]",GO:0003723; GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006091; GO:0016829; GO:0022600; GO:0043226; GO:0055086,RNA binding; catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; cytosol; generation of precursor metabolites and energy; lyase activity; digestive system process; organelle; nucleobase-containing small molecule metabolic process
OG_08516,1.0123717496874112,FUN_037445-T1,Peve_00027035,Pocillopora_meandrina_HIv1___RNAseq.g10976.t1,three_way,56.40266666666667,FUN_037445-T1,Q56UN5,M3K19_HUMAN,,"Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)",Homo sapiens (Human),61.7,274.0,1.7999999999999997e-95,353.2,sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens OX=9606 GN=MAP3K19 PE=2 SV=1,GO:0000165; GO:0004709; GO:0005524; GO:0106310,MAPK cascade [GO:0000165],,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_08384,1.0102093610097067,FUN_036983-T1,Peve_00003610,Pocillopora_meandrina_HIv1___RNAseq.g26799.t1,three_way,71.97066666666667,FUN_036983-T1,P18293,ANPRA_MOUSE,,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),Mus musculus (Mouse),38.7,1036.0,8.099999999999999e-189,662.5,sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2,GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0007168; GO:0008217; GO:0010753; GO:0016020; GO:0016941; GO:0017046; GO:0019934; GO:0042417; GO:0043235; GO:0048662; GO:0097746; GO:1990620,blood vessel diameter maintenance [GO:0097746]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217],ANPR-A receptor complex [GO:1990620]; membrane [GO:0016020]; receptor complex [GO:0043235],ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672],GO:0003013; GO:0003824; GO:0009975; GO:0016740; GO:0016829; GO:0060089; GO:0140096,"circulatory system process; catalytic activity; cyclase activity; transferase activity; lyase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_03122,1.0052451970435603,FUN_012476-T1,Peve_00004005,Pocillopora_meandrina_HIv1___RNAseq.g23990.t1,three_way,74.48633333333333,FUN_012476-T1,O15247,CLIC2_HUMAN,,Chloride intracellular channel protein 2 (Glutaredoxin-like oxidoreductase CLIC2) (EC 1.8.-.-) (Glutaredoxin-like peroxidase CLIC2) (EC 1.11.1.-) (XAP121),Homo sapiens (Human),31.7,230.0,1.5e-23,111.3,sp|O15247|CLIC2_HUMAN Chloride intracellular channel protein 2 OS=Homo sapiens OX=9606 GN=CLIC2 PE=1 SV=3,GO:0004602; GO:0005254; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006821; GO:0007165; GO:0010880; GO:0010881; GO:0016020; GO:0034707,chloride transport [GO:0006821]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165],chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; glutathione peroxidase activity [GO:0004602],GO:0003824; GO:0005215; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016209; GO:0016491; GO:0043226,catalytic activity; transporter activity; nucleus; nucleoplasm; cytosol; plasma membrane; antioxidant activity; oxidoreductase activity; organelle
OG_09693,1.0011140248592731,FUN_041922-T1,Peve_00007867,Pocillopora_meandrina_HIv1___RNAseq.g15626.t1,three_way,82.96933333333334,FUN_041922-T1,Q5I0R4,,,,,53.6,222.0,4.2e-63,242.7,sp|Q5I0R4|CF300_XENTR Cilia- and flagella-associated protein 300 OS=Xenopus tropicalis OX=8364 GN=cfap300 PE=2 SV=1,,,,,,
OG_08911,0.9976639224916428,FUN_038345-T1,Peve_00000092,Pocillopora_meandrina_HIv1___RNAseq.g1104.t1,three_way,95.93,FUN_038345-T1,A4IHR1,IT70A_XENTR,,Intraflagellar transport protein 70A (Tetratricopeptide repeat protein 30A) (TPR repeat protein 30A),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),78.8,646.0,2e-307,1055.8,sp|A4IHR1|IT70A_XENTR Intraflagellar transport protein 70A OS=Xenopus tropicalis OX=8364 GN=ift70a PE=2 SV=1,GO:0001501; GO:0001822; GO:0005879; GO:0005929; GO:0018095; GO:0042073; GO:0060271,cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; protein polyglutamylation [GO:0018095]; skeletal system development [GO:0001501],axonemal microtubule [GO:0005879]; cilium [GO:0005929],,GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_06913,0.9925610006032,FUN_031974-T2,Peve_00043636,Pocillopora_meandrina_HIv1___TS.g22504.t1,three_way,69.29716666666667,FUN_031974-T2,Q866F4,,,,,31.2,818.0,1.2e-97,360.5,sp|Q866F4|ADCYA_RABIT Adenylate cyclase type 10 OS=Oryctolagus cuniculus OX=9986 GN=ADCY10 PE=2 SV=1,,,,,,
OG_05640,0.990044694762686,FUN_025348-T1,Peve_00004327,Pocillopora_meandrina_HIv1___TS.g2360.t1a,three_way,40.693666666666665,,,,,,,,,,,,,,,,,
OG_09384,0.985135342139388,FUN_040673-T1,Peve_00015420,Pocillopora_meandrina_HIv1___RNAseq.g6458.t1,three_way,49.12566666666667,,,,,,,,,,,,,,,,,
OG_06323,0.9851337293652224,FUN_028831-T1,Peve_00024573,Pocillopora_meandrina_HIv1___RNAseq.g20708.t1,three_way,60.382666666666665,FUN_028831-T1,Q9NVH0,EXD2_HUMAN,,Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2),Homo sapiens (Human),34.2,669.0,3.8e-100,367.5,sp|Q9NVH0|EXD2_HUMAN Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EXD2 PE=1 SV=2,GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090304; GO:0090734,DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid metabolic process [GO:0090304]; replication fork processing [GO:0031297],cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734],3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310],GO:0003824; GO:0005634; GO:0005739; GO:0005856; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; mitochondrion; cytoskeleton; DNA repair; DNA recombination; hydrolase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_01418,0.9845628948102492,FUN_005725-T1,Peve_00039545,Pocillopora_meandrina_HIv1___RNAseq.g19424.t1,three_way,40.257666666666665,,,,,,,,,,,,,,,,,
OG_04621,0.9790088686684982,FUN_022323-T1,Peve_00021645,Pocillopora_meandrina_HIv1___RNAseq.g4644.t1,three_way,86.14483333333334,,,,,,,,,,,,,,,,,
OG_00215,0.9745549153079398,FUN_000934-T1,Peve_00009728,Pocillopora_meandrina_HIv1___RNAseq.g29458.t1,three_way,74.37933333333334,FUN_000934-T1,Q9BW85,YJU2_HUMAN,,Splicing factor YJU2 (Coiled-coil domain-containing protein 94),Homo sapiens (Human),68.8,173.0,7.7e-64,245.7,sp|Q9BW85|YJU2_HUMAN Splicing factor YJU2 OS=Homo sapiens OX=9606 GN=YJU2 PE=1 SV=1,GO:0000349; GO:0005654; GO:0008380; GO:0043518; GO:0046872; GO:0071006,"generation of catalytic spliceosome for first transesterification step [GO:0000349]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]",nucleoplasm [GO:0005654]; U2-type catalytic step 1 spliceosome [GO:0071006],metal ion binding [GO:0046872],GO:0005654; GO:0065003,nucleoplasm; protein-containing complex assembly
OG_01995,0.9741622772826026,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_06757,0.9709088344440296,FUN_031570-T1,Peve_00021507,Pocillopora_meandrina_HIv1___RNAseq.g5065.t1,three_way,57.521,FUN_031570-T1,D4A218,,,,,32.0,303.0,1.1e-26,122.5,sp|D4A218|DMRT3_RAT Doublesex and mab-3 related transcription factor 3 OS=Rattus norvegicus OX=10116 GN=Dmrt3 PE=3 SV=1,,,,,,
OG_07731,0.9708466737357176,FUN_034892-T1,Peve_00037338,Pocillopora_meandrina_HIv1___TS.g15150.t1,three_way,61.52,,,,,,,,,,,,,,,,,
OG_05543,0.96460509733398,FUN_024749-T1,Peve_00005929,Pocillopora_meandrina_HIv1___RNAseq.g18845.t1,three_way,56.452666666666666,,,,,,,,,,,,,,,,,
OG_03743,0.9533388607169556,FUN_015050-T1,Peve_00001172,Pocillopora_meandrina_HIv1___RNAseq.g21265.t1,three_way,70.01583333333333,FUN_015050-T1,Q8CHW5,,,,,38.3,120.0,7.4e-10,67.4,sp|Q8CHW5|BICL2_MOUSE BICD family-like cargo adapter 2 OS=Mus musculus OX=10090 GN=Bicdl2 PE=1 SV=1,,,,,,
OG_01620,0.9532603799636034,FUN_006729-T1,Peve_00039560,Pocillopora_meandrina_HIv1___RNAseq.g20015.t1,three_way,68.16666666666667,FUN_006729-T1,O55240,RDH5_MOUSE,,Retinol dehydrogenase 5 (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (11-cis retinol dehydrogenase) (11-cis RDH) (11-cis RoDH) (9-cis retinol dehydrogenase) (Cis-retinol dehydrogenase),Mus musculus (Mouse),44.6,285.0,1.7999999999999994e-68,261.2,sp|O55240|RDH5_MOUSE Retinol dehydrogenase 5 OS=Mus musculus OX=10090 GN=Rdh5 PE=1 SV=1,GO:0001523; GO:0004745; GO:0005788; GO:0005789; GO:0007601; GO:0008202; GO:0042572; GO:0042803; GO:0044297; GO:0047023; GO:0047044; GO:0106429,retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; visual perception [GO:0007601],cell body [GO:0044297]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],"11-cis-retinol dehydrogenase [GO:0106429]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0006629; GO:0016491; GO:0050877,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process
OG_06691,0.95120500056379,FUN_031236-T1,Peve_00043063,Pocillopora_meandrina_HIv1___RNAseq.g5195.t1,three_way,57.85166666666667,FUN_031236-T1,Q8NA75,,,,,33.1,278.0,1.8999999999999998e-39,164.9,sp|Q8NA75|DC4L2_HUMAN DDB1- and CUL4-associated factor 4-like protein 2 OS=Homo sapiens OX=9606 GN=DCAF4L2 PE=1 SV=1,,,,,,
OG_05813,0.9488612131052686,FUN_025815-T1,Peve_00002524,Pocillopora_meandrina_HIv1___RNAseq.g9337.t1,three_way,46.56366666666667,FUN_025815-T1,O35565,FGF10_MOUSE,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Mus musculus (Mouse),32.5,126.0,2e-11,71.2,sp|O35565|FGF10_MOUSE Fibroblast growth factor 10 OS=Mus musculus OX=10090 GN=Fgf10 PE=2 SV=1,GO:0000132; GO:0000278; GO:0001525; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005111; GO:0005615; GO:0005634; GO:0005886; GO:0006935; GO:0007267; GO:0007368; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008544; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010468; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0030036; GO:0030177; GO:0030324; GO:0030538; GO:0030855; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0035108; GO:0035265; GO:0042056; GO:0042060; GO:0042246; GO:0042472; GO:0042475; GO:0042693; GO:0043616; GO:0045739; GO:0045747; GO:0045893; GO:0045931; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048286; GO:0048514; GO:0048536; GO:0048538; GO:0048557; GO:0048565; GO:0048566; GO:0048645; GO:0048730; GO:0048752; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060173; GO:0060174; GO:0060425; GO:0060428; GO:0060430; GO:0060436; GO:0060441; GO:0060445; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060541; GO:0060594; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in salivary gland morphogenesis [GO:0060445]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; inner ear morphogenesis [GO:0042472]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mammary gland specification [GO:0060594]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros morphogenesis [GO:0003338]; mitotic cell cycle [GO:0000278]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; positive regulation of Wnt signaling pathway [GO:0030177]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of gene expression [GO:0010468]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; respiratory system development [GO:0060541]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland morphogenesis [GO:0007435]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; semicircular canal morphogenesis [GO:0048752]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0000278; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_08361,0.9437837199529622,FUN_036910-T1,Peve_00018417,Pocillopora_meandrina_HIv1___RNAseq.g10815.t1,three_way,60.812666666666665,,,,,,,,,,,,,,,,,
OG_08337,0.9373440700610178,FUN_036850-T1,Peve_00036530,Pocillopora_meandrina_HIv1___RNAseq.g10652.t1,three_way,46.763666666666666,,,,,,,,,,,,,,,,,
OG_01034,0.9263777026194924,FUN_004469-T1,Peve_00007167,Pocillopora_meandrina_HIv1___RNAseq.g4952.t1,three_way,86.357,FUN_004469-T1,P14211,CALR_MOUSE,,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP),Mus musculus (Mouse),77.3,198.0,5.6e-85,315.5,sp|P14211|CALR_MOUSE Calreticulin OS=Mus musculus OX=10090 GN=Calr PE=1 SV=1,GO:0000122; GO:0001669; GO:0001849; GO:0002502; GO:0003729; GO:0005049; GO:0005178; GO:0005506; GO:0005509; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0005840; GO:0006611; GO:0007283; GO:0008284; GO:0009410; GO:0009897; GO:0010595; GO:0010628; GO:0016020; GO:0017148; GO:0030246; GO:0030866; GO:0031625; GO:0032355; GO:0033018; GO:0033144; GO:0033574; GO:0034504; GO:0040020; GO:0042277; GO:0042562; GO:0042824; GO:0044183; GO:0044194; GO:0044322; GO:0045335; GO:0045665; GO:0045787; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0055007; GO:0060473; GO:0071257; GO:0071285; GO:0090398; GO:0098586; GO:0098794; GO:0098978; GO:0140313; GO:1900026; GO:1901164; GO:1901224; GO:1901652; GO:1903416; GO:1904614; GO:2000510,cardiac muscle cell differentiation [GO:0055007]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]; response to biphenyl [GO:1904614]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to peptide [GO:1901652]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynapse [GO:0098794]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],GO:0003723; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0005840; GO:0006355; GO:0006886; GO:0006913; GO:0007010; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044183; GO:0065003; GO:0140104; GO:0140313,RNA binding; extracellular region; extracellular space; nuclear envelope; mitochondrion; lysosome; vacuole; endoplasmic reticulum; cytosol; ribosome; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; protein folding chaperone; protein-containing complex assembly; molecular carrier activity; molecular sequestering activity
OG_01168,0.9199074052817818,FUN_004791-T1,Peve_00010255,Pocillopora_meandrina_HIv1___RNAseq.g8522.t1,three_way,63.762,FUN_004791-T1,P56705,WNT4_HUMAN,,Protein Wnt-4,Homo sapiens (Human),39.4,322.0,1.8999999999999998e-62,241.1,sp|P56705|WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens OX=9606 GN=WNT4 PE=1 SV=4,GO:0001658; GO:0001822; GO:0001837; GO:0001838; GO:0001889; GO:0003714; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0008543; GO:0008584; GO:0008585; GO:0009267; GO:0009986; GO:0010629; GO:0010894; GO:0022407; GO:0030182; GO:0030237; GO:0030325; GO:0030336; GO:0030501; GO:0030666; GO:0031012; GO:0032349; GO:0032967; GO:0033080; GO:0035567; GO:0040037; GO:0042445; GO:0043410; GO:0045165; GO:0045596; GO:0045669; GO:0045836; GO:0045892; GO:0045893; GO:0048018; GO:0048599; GO:0051145; GO:0051496; GO:0051894; GO:0060008; GO:0060070; GO:0060126; GO:0060129; GO:0060231; GO:0060748; GO:0061045; GO:0061180; GO:0061184; GO:0061205; GO:0061369; GO:0070062; GO:0071560; GO:0072033; GO:0072034; GO:0072162; GO:0072174; GO:0072273; GO:0097190; GO:0140013; GO:1904238; GO:2000019; GO:2000066; GO:2000180; GO:2000225; GO:2001234,adrenal gland development [GO:0030325]; apoptotic signaling pathway [GO:0097190]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; meiotic nuclear division [GO:0140013]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; pericyte cell differentiation [GO:1904238]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; Sertoli cell differentiation [GO:0060008]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005576; GO:0005615; GO:0005886; GO:0006355; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048018; GO:0048856; GO:0060090; GO:0098772; GO:0140013; GO:0140110,immune system process; extracellular region; extracellular space; plasma membrane; regulation of DNA-templated transcription; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; receptor ligand activity; anatomical structure development; molecular adaptor activity; molecular function regulator activity; meiotic nuclear division; transcription regulator activity
OG_04999,0.9189518522731894,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_09753,0.916303196431276,FUN_042023-T1,Peve_00044157,Pocillopora_meandrina_HIv1___RNAseq.g15167.t1,three_way,91.09866666666666,FUN_042023-T1,Q0V9R4,,,,,42.4,877.0,1.1e-163,578.9,sp|Q0V9R4|CCD39_XENTR Coiled-coil domain-containing protein 39 OS=Xenopus tropicalis OX=8364 GN=ccdc39 PE=2 SV=1,,,,,,
OG_03084,0.9161409278807808,FUN_012357-T1,Peve_00042558,Pocillopora_meandrina_HIv1___TS.g16156.t2,three_way,49.562333333333335,,,,,,,,,,,,,,,,,
OG_08941,0.9142324858435792,FUN_038410-T1,Peve_00000012,Pocillopora_meandrina_HIv1___RNAseq.g28285.t1,three_way,90.88266666666668,FUN_038410-T1,Q66IZ7,,,,,48.4,287.0,1.4e-49,198.4,sp|Q66IZ7|NDL1B_XENLA Nuclear distribution protein nudE-like 1-B OS=Xenopus laevis OX=8355 GN=ndel1-b PE=2 SV=1,,,,,,
OG_05094,0.908591686007414,FUN_023341-T1,Peve_00023294,Pocillopora_meandrina_HIv1___RNAseq.g17422.t2,three_way,63.56933333333334,FUN_023341-T1,O15066,KIF3B_HUMAN,,"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]",Homo sapiens (Human),28.9,557.0,1.3000000000000002e-44,183.7,sp|O15066|KIF3B_HUMAN Kinesin-like protein KIF3B OS=Homo sapiens OX=9606 GN=KIF3B PE=1 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016192; GO:0016887; GO:0016939; GO:0030425; GO:0030496; GO:0031267; GO:0032467; GO:0032839; GO:0036372; GO:0042073; GO:0043197; GO:0060271; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0098971; GO:0098978; GO:0120170; GO:1904115,anterograde axonal transport [GO:0008089]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; opsin transport [GO:0036372]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; vesicle-mediated transport [GO:0016192],axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; small GTPase binding [GO:0031267],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_07340,0.9080176953715352,FUN_033745-T1,Peve_00004929,Pocillopora_meandrina_HIv1___RNAseq.g28757.t1,three_way,54.01,FUN_033745-T1,Q8QGQ6,CLOCK_CHICK,,Circadian locomoter output cycles protein kaput,Gallus gallus (Chicken),37.6,367.0,2.7000000000000002e-58,228.0,sp|Q8QGQ6|CLOCK_CHICK Circadian locomoter output cycles protein kaput OS=Gallus gallus OX=9031 GN=CLOCK PE=1 SV=2,GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005829; GO:0006357; GO:0006473; GO:0006974; GO:0032922; GO:0046983; GO:0051775; GO:0070888; GO:1990513,circadian regulation of gene expression [GO:0032922]; DNA damage response [GO:0006974]; protein acetylation [GO:0006473]; regulation of transcription by RNA polymerase II [GO:0006357]; response to redox state [GO:0051775],CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_02475,0.905926657165133,FUN_009736-T1,Peve_00033566,Pocillopora_meandrina_HIv1___RNAseq.g29063.t1,three_way,57.04183333333333,FUN_009736-T1,G5EBQ8,CHS2_CAEEL,,Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2),Caenorhabditis elegans,32.1,764.0,9.100000000000001e-104,380.6,sp|G5EBQ8|CHS2_CAEEL Chitin synthase chs-2 OS=Caenorhabditis elegans OX=6239 GN=chs-2 PE=1 SV=1,GO:0004100; GO:0005886; GO:0006031; GO:0061063,chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063],plasma membrane [GO:0005886],chitin synthase activity [GO:0004100],GO:0003824; GO:0005886; GO:0016740; GO:1901135,catalytic activity; plasma membrane; transferase activity; carbohydrate derivative metabolic process
OG_07659,0.9043048564270812,FUN_034604-T1,Peve_00037084,Pocillopora_meandrina_HIv1___TS.g18635.t1,three_way,65.48566666666666,FUN_034604-T1,Q90XE6,KLF1_DANRE,,Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d),Danio rerio (Zebrafish) (Brachydanio rerio),80.0,80.0,5.7e-08,59.7,sp|Q90XE6|KLF1_DANRE Kruppel-like factor 1 OS=Danio rerio OX=7955 GN=klf1 PE=2 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0008270; GO:0010628; GO:0010725; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0055007; GO:0060038; GO:0060319,animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0007010; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05183,0.9026706286567362,FUN_023529-T1,Peve_00044316,Pocillopora_meandrina_HIv1___TS.g7657.t1,three_way,73.594,,,,,,,,,,,,,,,,,
OG_07050,0.9015621349390502,FUN_032270-T1,Peve_00014263,Pocillopora_meandrina_HIv1___RNAseq.g24972.t1,three_way,76.632,,,,,,,,,,,,,,,,,
OG_00047,0.9010882677275744,FUN_000283-T1,Peve_00033555,Pocillopora_meandrina_HIv1___RNAseq.g29073.t1,three_way,79.09333333333333,FUN_000283-T1,Q9I8C7,,,,,46.3,322.0,4.6e-86,320.1,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_07699,0.8994675198786614,FUN_034833-T1,Peve_00010451,Pocillopora_meandrina_HIv1___RNAseq.g27185.t1,three_way,51.098,,,,,,,,,,,,,,,,,
OG_05777,0.8982449565339594,FUN_025746-T1,Peve_00008534,Pocillopora_meandrina_HIv1___RNAseq.g10426.t1,three_way,57.30083333333333,FUN_025746-T1,Q6P132,,,,,40.8,152.0,1.9999999999999998e-32,142.9,sp|Q6P132|TXB1B_DANRE Tax1-binding protein 1 homolog B OS=Danio rerio OX=7955 GN=tax1bp1b PE=2 SV=3,,,,,,
OG_08491,0.8975542893688649,FUN_037330-T1,Peve_00006234,Pocillopora_meandrina_HIv1___RNAseq.g10692.t1,three_way,60.120000000000005,FUN_037330-T1,Q8IVV2,,,,,39.6,273.0,5.8e-47,192.2,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_09110,0.8972729982442638,FUN_039036-T1,Peve_00028756,Pocillopora_meandrina_HIv1___RNAseq.g28692.t1,three_way,82.128,FUN_039036-T1,Q8N8E3,,,,,40.0,442.0,1.5e-65,251.9,sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2,,,,,,
OG_02000,0.8897449753226951,FUN_008111-T1,Peve_00022340,Pocillopora_meandrina_HIv1___RNAseq.g17893.t1,three_way,53.2585,FUN_008111-T1,B3EWY9,,,,,33.3,1402.0,3.9e-139,498.4,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_06676,0.8884948866842328,FUN_031079-T1,Peve_00028146,Pocillopora_meandrina_HIv1___RNAseq.27627_t,three_way,61.867666666666665,,,,,,,,,,,,,,,,,
OG_08928,0.88575746652433,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_07250,0.8842588555173582,FUN_032992-T1,Peve_00014540,Pocillopora_meandrina_HIv1___RNAseq.g24473.t1,three_way,73.003,FUN_032992-T1,Q8RCT3,,,,,57.0,302.0,2.5e-88,328.2,sp|Q8RCT3|PSUG_CALS4 Pseudouridine-5'-phosphate glycosidase OS=Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) OX=273068 GN=psuG PE=3 SV=1,,,,,,
OG_00163,0.8807833436246519,FUN_000637-T1,Peve_00012867,Pocillopora_meandrina_HIv1___RNAseq.g16016.t1,three_way,83.68833333333333,FUN_000637-T1,O97125,,,,,74.2,613.0,9.1e-265,914.1,sp|O97125|HSP68_DROME Heat shock protein 68 OS=Drosophila melanogaster OX=7227 GN=Hsp68 PE=1 SV=1,,,,,,
OG_05305,0.8777791261578245,FUN_023978-T1,Peve_00020874,Pocillopora_meandrina_HIv1___RNAseq.g19435.t1,three_way,47.72816666666667,,,,,,,,,,,,,,,,,
OG_04408,0.8770231972941579,FUN_018426-T1,Peve_00031692,Pocillopora_meandrina_HIv1___TS.g23699.t1,three_way,67.75733333333334,,,,,,,,,,,,,,,,,
OG_05198,0.876541811607269,FUN_023578-T1,Peve_00035142,Pocillopora_meandrina_HIv1___RNAseq.g3534.t2,three_way,64.644,FUN_023578-T1,O95786,RIGI_HUMAN,,Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),Homo sapiens (Human),35.5,716.0,2.1e-106,388.7,sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2,GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005829; GO:0005856; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; cytosol; cytoskeleton; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; molecular transducer activity; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_01396,0.8747104781104675,FUN_005372-T2,Peve_00041488,Pocillopora_meandrina_HIv1___RNAseq.g6635.t1,three_way,84.41483333333333,FUN_005372-T2,P19120,HSP7C_BOVIN,,Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8),Bos taurus (Bovine),82.6,650.0,4.8e-293,1008.1,sp|P19120|HSP7C_BOVIN Heat shock cognate 71 kDa protein OS=Bos taurus OX=9913 GN=HSPA8 PE=1 SV=2,GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0016191; GO:0016887; GO:0030674; GO:0031072; GO:0042026; GO:0042470; GO:0044183; GO:0045892; GO:0051085; GO:0061740; GO:0072318; GO:0098793; GO:0140662; GO:1990904,chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; RNA splicing [GO:0008380]; synaptic vesicle uncoating [GO:0016191],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0006457; GO:0006886; GO:0016071; GO:0016787; GO:0031410; GO:0043226; GO:0044183; GO:0060090; GO:0140657,catalytic activity; nucleus; nucleolus; cytosol; plasma membrane; regulation of DNA-templated transcription; protein folding; intracellular protein transport; mRNA metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; protein folding chaperone; molecular adaptor activity; ATP-dependent activity
OG_09043,0.8694911859810175,FUN_038697-T1,Peve_00013468,Pocillopora_meandrina_HIv1___RNAseq.g26461.t2,three_way,78.3395,FUN_038697-T1,Q9Y383,LC7L2_HUMAN,,Putative RNA-binding protein Luc7-like 2,Homo sapiens (Human),60.3,239.0,6.6e-79,295.8,sp|Q9Y383|LC7L2_HUMAN Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens OX=9606 GN=LUC7L2 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004,mRNA splice site recognition [GO:0006376],nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004],enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0043226; GO:0065003,RNA binding; organelle; protein-containing complex assembly
OG_04620,0.8676152373165968,FUN_022322-T1,Peve_00021644,Pocillopora_meandrina_HIv1___RNAseq.g4643.t1,three_way,86.02233333333332,,,,,,,,,,,,,,,,,
OG_00838,0.8650104075279809,FUN_004088-T1,Peve_00024024,Pocillopora_meandrina_HIv1___RNAseq.29948_t,three_way,59.1695,FUN_004088-T1,Q0KIA2,,,,,44.8,232.0,3.5e-49,197.6,sp|Q0KIA2|Y9801_DROME PP2C-like domain-containing protein CG9801 OS=Drosophila melanogaster OX=7227 GN=CG9801 PE=2 SV=1,,,,,,
OG_07120,0.8644747925431407,FUN_032405-T1,Peve_00009164,Pocillopora_meandrina_HIv1___RNAseq.g29839.t1,three_way,82.7025,FUN_032405-T1,Q6GNS3,,,,,57.4,509.0,6.3000000000000005e-168,592.0,sp|Q6GNS3|NMD3_XENLA 60S ribosomal export protein NMD3 OS=Xenopus laevis OX=8355 GN=nmd3 PE=2 SV=1,,,,,,
OG_07394,0.8641556192341463,FUN_033824-T1,Peve_00028770,Pocillopora_meandrina_HIv1___RNAseq.g26355.t1,three_way,53.976,,,,,,,,,,,,,,,,,
OG_03853,0.8615555073846421,FUN_015345-T1,Peve_00011268,Pocillopora_meandrina_HIv1___RNAseq.g21720.t1,three_way,74.91566666666667,FUN_015345-T1,Q5M7F8,,,,,39.9,138.0,9.200000000000001e-22,105.1,sp|Q5M7F8|CM2CA_XENLA Ciliary microtubule inner protein 2C OS=Xenopus laevis OX=8355 GN=cimip2ca PE=2 SV=1,,,,,,
OG_01897,0.8579236358220712,FUN_007904-T1,Peve_00040656,Pocillopora_meandrina_HIv1___RNAseq.g30059.t1,three_way,60.9685,FUN_007904-T1,P06582,,,,,37.0,100.0,1.1e-11,72.0,sp|P06582|HSP12_CAEEL Heat shock protein hsp-16.2 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.2 PE=2 SV=1,,,,,,
OG_02303,0.8561472719927432,FUN_008882-T1,Peve_00032041,Pocillopora_meandrina_HIv1___RNAseq.g14468.t1,three_way,62.712,FUN_008882-T1,Q32KN7,,,,,41.7,192.0,3.3e-26,120.9,sp|Q32KN7|ZC21B_BOVIN Zinc finger C2HC domain-containing protein 1B OS=Bos taurus OX=9913 GN=ZC2HC1B PE=2 SV=1,,,,,,
OG_07132,0.85569115480618,FUN_032433-T1,Peve_00038721,Pocillopora_meandrina_HIv1___RNAseq.g20796.t1b,three_way,50.24216666666667,FUN_032433-T1,Q12789,TF3C1_HUMAN,,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),Homo sapiens (Human),25.0,1605.0,2.7e-101,372.9,sp|Q12789|TF3C1_HUMAN General transcription factor 3C polypeptide 1 OS=Homo sapiens OX=9606 GN=GTF3C1 PE=1 SV=4,GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904,5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797],membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127],DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995],GO:0003677; GO:0005654; GO:0005730; GO:0006351; GO:0006399; GO:0043226; GO:0140223,DNA binding; nucleoplasm; nucleolus; DNA-templated transcription; tRNA metabolic process; organelle; general transcription initiation factor activity
OG_05726,0.8543491137241438,FUN_025649-T1,Peve_00039652,Pocillopora_meandrina_HIv1___RNAseq.g23087.t2c,three_way,52.45816666666667,,,,,,,,,,,,,,,,,
OG_02759,0.8533054016418153,FUN_011696-T1,Peve_00010715,Pocillopora_meandrina_HIv1___RNAseq.g23904.t1,three_way,73.33366666666667,FUN_011696-T1,A8XJZ8,,,,,45.2,93.0,1.1e-14,83.2,sp|A8XJZ8|LST2_CAEBR Lateral signaling target protein 2 OS=Caenorhabditis briggsae OX=6238 GN=lst-2 PE=3 SV=1,,,,,,
OG_03677,0.8518835645516757,FUN_014931-T1,Peve_00037145,Pocillopora_meandrina_HIv1___RNAseq.g21089.t1,three_way,68.721,FUN_014931-T1,Q4FAT7,,,,,40.9,580.0,7.9e-123,442.6,sp|Q4FAT7|BGLR_PIG Beta-glucuronidase OS=Sus scrofa OX=9823 GN=GUSB PE=3 SV=1,,,,,,
OG_09698,0.8502098974197817,FUN_041929-T1,Peve_00022681,Pocillopora_meandrina_HIv1___RNAseq.g15697.t1,three_way,59.108,FUN_041929-T1,Q6AYB8,GO45_RAT,,Golgin-45 (Basic leucine zipper nuclear factor 1),Rattus norvegicus (Rat),29.6,422.0,1.5e-25,119.0,sp|Q6AYB8|GO45_RAT Golgin-45 OS=Rattus norvegicus OX=10116 GN=Blzf1 PE=1 SV=1,GO:0000139; GO:0005634; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001,Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005794; GO:0016192; GO:0043226; GO:0072659,nucleus; Golgi apparatus; vesicle-mediated transport; organelle; protein localization to plasma membrane
